| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.27B | +26.8% |
| Gross profit | ¥0.06B | — |
| Operating income | ¥0.02B | — |
| Net income | ¥0.02B | +48.8% |
| Gross margin | 21.6% | Net margin 7.2% |
| Revenue Q/Q | +19.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.21B | 78.4% |
| R&D | ¥0.01B | 5.0% |
| SG&A | ¥0.02B | 6.0% |
| Tax & other | ¥0.00B | 0.7% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
本川智能 ・ 恒宇信通 ・ 共同药业 ・ 晓鸣股份 ・ 格林精密 ・ 恒帅股份 ・ 华绿生物 ・ 博亚精工 ・ 万辰集团 ・ 立高食品 ・ 商络电子 ・ 达瑞电子
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies